Sumatriptan succinate

Sumatriptan succinate (CAS 103628-48-4, EC 600-463-4) is a pharmaceutical active ingredient belonging to the triptan class, commercially recognised under trade names including Imitrex, Imigran, Imigrane, Megrelan, and Sumitrex. It carries no assigned E-code and is classified under HS code 29350090 within pharmaceutical intermediates.

In pharmaceutical formulations, sumatriptan succinate acts as a selective serotonin receptor agonist, making it the functional basis of migraine and cluster headache treatments in oral, injectable, and nasal delivery systems. In personal care research contexts, it has been investigated for skin-conditioning and antimicrobial activity, functioning through membrane-level interactions with microbial targets.

Sumatriptan succinate is supplied as a white crystalline powder meeting Ph.Eur. and ICH pharmaceutical grade specifications, with REACH compliance applicable for EU procurement. Standard packaging formats include sealed HDPE drums and double-polyethylene-lined fibre drums, with quantities available from research scale through commercial bulk.